Literature DB >> 6982938

Anti-Sm autoantibodies in MRL mice: in vitro detection and generation of antibody-forming cells.

P L Cohen, R A Eisenberg.   

Abstract

Antibodies to the nuclear antigen SM are specific for systemic lupus erythematosus in humans and mice. In order to study the cellular mechanisms of anti-Sm generation, a hemolytic plaque assay to identify and enumerate lymphocytes secreting anti-Sm has been developed by using SRBC coated with purified Sm by a modified carbodiimide technique. Anti-Sm-specific PFC were found in MRL/Mp-Ipr/Ipr and MLR/Mp- +/+ mice whose sera contained anti-Sm, but were never detected in anti-Sm-negative MRL mice or in normals. Spleen cells from anti-Sm-positive MRL/Mp-Ipr/Ipr mice generated anti-Sm PFC spontaneously after 4 days of in vitro culture, whereas cells from normal mice or anti-Sm-negative MRL mice were never observed to produce spontaneous anti-Sm, even when cultured in the presence of bacterial lipopolysaccharide. The generation of anti-Sm by MRL cells in vitro was found to be dependent on the presence of T cells, but the ability of cells from individual MRL mice to generate anti-Sm appeared to be limited by the availability of Sm-specific B cell precursors and not due to a relative absence of T cells capable of providing help for the anti-Sm response. Analysis at the cellular level of the in vitro generation of a disease-specific autoantibody by using the methods described should facilitate understanding of mechanisms of autoreactivity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982938

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Accelerated expression of anti-Sm and Y2 idiotype differ in dependence on T cell subsets in MRL/+ mice.

Authors:  M L Miller; H Dang; N Talal
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  Differential induction of lupus associated antinuclear antibodies in MRL mice by monoclonal anti-Sm antibodies.

Authors:  M R Stocks; D G Williams; R N Maini
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

4.  Active role of T cells in promoting an in vitro autoantibody response to self erythrocytes in NZB mice.

Authors:  R D Miller; C E Calkins
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

5.  Further characterization of the autoantibody response of Palmerston North mice.

Authors:  B S Handwerger; C E Storrer; C S Wasson; F Movafagh; M Reichlin
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

6.  Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.

Authors:  Junichiro Irie; Yuehong Wu; David A Sass; William M Ridgway
Journal:  Immunogenetics       Date:  2006-01-27       Impact factor: 2.846

7.  Immunization with the Sm nuclear antigen induces anti-Sm antibodies in normal and MRL mice.

Authors:  E W Shores; D S Pisetsky; J Grudier; R A Eisenberg; P L Cohen
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

8.  Individual variation of anti-Sm autoantibodies in the MRL/MP-lpr/lpr mouse: age-related increase in diversity.

Authors:  D G Williams; F M Brennan; M R Stocks; R N Maini
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

9.  Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.

Authors:  R A Eisenberg; K Dyer; S Y Craven; C R Fuller; W J Yount
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

10.  Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.

Authors:  B J Weill; M L Renoux
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.